Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trialAdrian F. Hernandez, Lauren B. Cooper, Karl M. Thorpe et al.|The Lancet|2018Cited by 1.8k
Risk Factor Burden and Long‐Term Prognosis of Patients With Premature Coronary Artery DiseaseMichel Zeitouni, W. Schuyler Jones, Robert M. Clare et al.|Journal of the American Heart Association|2020Cited by 159
The China Acute Myocardial Infarction (CAMI) Registry: A national long-term registry-research-education integrated platform for exploring acute myocardial infarction in ChinaHaiyan Xu, Yuejin Yang, Jingang Yang et al.|American Heart Journal|2015Cited by 133
Impact of Regulatory Guidance on Evaluating Cardiovascular Risk of New Glucose-Lowering Therapies to Treat Type 2 Diabetes MellitusAbhinav Sharma, Christopher B. Granger, Neha J. Pagidipati et al.|Circulation|2020Cited by 108
Long‐Term Mortality of Older Patients With Acute Myocardial Infarction Treated in US Clinical PracticeAjar Kochar, Tracy Y. Wang, Anita Y. Chen et al.|Journal of the American Heart Association|2018Cited by 91